This is a list of all content pages that are marked reviewed, but after the review it was subsequently edited. Presumably these pages need to be reviewed again.
13201 reviews are up to date. 949 reviews are stale and are listed below.
- 10.3389/fevo.2022.742369/Experiment 1
- Genomic analysis identifies association of Fusobacterium with colorectal carcinoma/Experiment 1
- Genomic analysis identifies association of Fusobacterium with colorectal carcinoma/Experiment 2
- Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome/Experiment 1
- Comparison of the respiratory microbiome in healthy nonsmokers and smokers/Experiment 1
- Comparison of the respiratory microbiome in healthy nonsmokers and smokers/Experiment 2
- Comparison of the respiratory microbiome in healthy nonsmokers and smokers/Experiment 3
- Comparison of the respiratory microbiome in healthy nonsmokers and smokers/Experiment 4
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 2
- High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 3
- Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection/Experiment 1
- Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection/Experiment 2
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 1
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 1/Signature 1
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 1/Signature 2
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 2
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 2/Signature 1
- Systematic analysis of the association between gut flora and obesity through high-throughput sequencing and bioinformatics approaches/Experiment 2/Signature 2
- Subgingival microbiome in smokers and non-smokers in Korean chronic periodontitis patients/Experiment 1
- Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer
- Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1
- The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes/Experiment 1
- Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study/Experiment 1
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 1
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 2
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 3
- Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)/Experiment 1
- Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects/Experiment 1
- The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin/Experiment 2
- Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls/Experiment 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 1/Signature 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 1/Signature 2
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 2
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 2/Signature 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 2/Signature 2
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 3
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 3/Signature 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 3/Signature 2
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 4
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 4/Signature 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 4/Signature 2
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 5
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 5/Signature 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 5/Signature 2
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 6
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 6/Signature 1
- Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome/Experiment 6/Signature 2
- Penile Anaerobic Dysbiosis as a Risk Factor for HIV Infection
- Penile Anaerobic Dysbiosis as a Risk Factor for HIV Infection/Experiment 1
- Penile Anaerobic Dysbiosis as a Risk Factor for HIV Infection/Experiment 1/Signature 1
- Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis/Experiment 1
- Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease/Experiment 1
- Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease/Experiment 2
- Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease/Experiment 3
- Distribution and Diversity of Ocular Microbial Communities in Diabetic Patients Compared with Healthy Subjects/Experiment 1
- The Influence of Age and Sex on Ocular Surface Microbiota in Healthy Adults/Experiment 1
- The Influence of Age and Sex on Ocular Surface Microbiota in Healthy Adults/Experiment 2
- Fiber-Mediated Nourishment of Gut Microbiota Protects against Diet-Induced Obesity by Restoring IL-22-Mediated Colonic Health
- Comparison of DNA extraction methods for human gut microbial community profiling
- Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 1
- Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 2
- Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 3
- Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 4
- Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 5
- Alterations in the gut microbiota of patients with acquired immune deficiency syndrome/Experiment 6
- A metagenomic study of the gut microbiome in Behcet's disease
- Human pharyngeal microbiota in age-related macular degeneration
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 1/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 1/Signature 2
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 2
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 2/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 2/Signature 2
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 3
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 3/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 4
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 4/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 4/Signature 2
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 5
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 5/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 5/Signature 2
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 6
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 6/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 6/Signature 2
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 7
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 7/Signature 1
- Human pharyngeal microbiota in age-related macular degeneration/Experiment 7/Signature 2
- Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy/Experiment 1
- Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy/Experiment 2
- Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy/Experiment 3
- Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy/Experiment 4
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 2/Signature 2
- Differential Analysis of Gut Microbiota Correlated With Oxidative Stress in Sows With High or Low Litter Performance During Lactation/Experiment 3/Signature 1
- Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health/Experiment 4
- A study of the correlation between obesity and intestinal flora in school-age children/Experiment 1
- Microbiota and Derived Parameters in Fecal Samples of Infants with Non-IgE Cow's Milk Protein Allergy under a Restricted Diet/Experiment 1
- Microbiota and Derived Parameters in Fecal Samples of Infants with Non-IgE Cow's Milk Protein Allergy under a Restricted Diet/Experiment 2
- Alterations of fecal bacterial communities in patients with lung cancer/Experiment 1
- Alterations of fecal bacterial communities in patients with lung cancer/Experiment 2
- Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function/Experiment 1
- Microbial biomarkers of common tongue coatings in patients with gastric cancer/Experiment 1
- Microbial biomarkers of common tongue coatings in patients with gastric cancer/Experiment 2
- Microbial biomarkers of common tongue coatings in patients with gastric cancer/Experiment 3
- Microbial biomarkers of common tongue coatings in patients with gastric cancer/Experiment 4
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 1
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 2
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 3
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 4
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 5
- Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 6
- The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls/Experiment 1
- The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls/Experiment 2
- The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls/Experiment 3/Signature 2
- Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study/Experiment 1
- Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study/Experiment 2
- The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy/Experiment 1
- The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy/Experiment 1/Signature 1
- The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy/Experiment 1/Signature 2
- Gut microbiota analysis and its significance in vasovagal syncope in children/Experiment 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 1/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 2
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 2/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 3
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 3/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 4
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 4/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 4/Signature 2
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 5
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 5/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 5/Signature 2
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 6
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 6/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 7
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 7/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 8
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 8/Signature 1
- Diversity of the Gut Microbiota in Dihydrotestosterone-Induced PCOS Rats and the Pharmacologic Effects of Diane-35, Probiotics, and Berberine/Experiment 8/Signature 2
- Blood Microbiome Profile in CKD : A Pilot Study/Experiment 1
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 6/Signature 2
- Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models/Experiment 11/Signature 1
- Dysbiosis of gut microbiota in a selected population of Parkinson's patients/Experiment 1
- Dysbiosis of gut microbiota in a selected population of Parkinson's patients/Experiment 2
- Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease/Experiment 1
- Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease/Experiment 2
- The Microbiome of Prostate Fluid Is Associated With Prostate Cancer/Experiment 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 1/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 1/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 2/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 2/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 3
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 3/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 3/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 4/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 5
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 5/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 5/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 6
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 6/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 6/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 7
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 7/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 7/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 8
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 8/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 8/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 9
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 9/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 9/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 10
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 10/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 10/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 11
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 11/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 11/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 12
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 12/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 12/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 13
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 13/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 13/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 14
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 14/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 14/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 15/Signature 2
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16/Signature 1
- Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16/Signature 2
- Cigarette smoking and oral microbiota in low-income and African-American populations/Experiment 1
- Cigarette smoking and oral microbiota in low-income and African-American populations/Experiment 2
- Cigarette smoking and oral microbiota in low-income and African-American populations/Experiment 3
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 1
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 3
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 4
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 5
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 1
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 2
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 3
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 4
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 5
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 6
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 7
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 8
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 9
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 10
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 11
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 12
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 13
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 14
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 15
- Effect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiota/Experiment 16
- Analysis of the Gut Microflora in Patients With Parkinson's Disease/Experiment 1
- Analysis of the Gut Microflora in Patients With Parkinson's Disease/Experiment 2
- Analysis of the Gut Microflora in Patients With Parkinson's Disease/Experiment 3
- Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study/Experiment 1
- Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing/Experiment 1
- Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing/Experiment 2
- Gut Microbiota Are Associated With Psychological Stress-Induced Defections in Intestinal and Blood-Brain Barriers/Experiment 1/Signature 2
- Gut microbiome structure and adrenocortical activity in dogs with aggressive and phobic behavioral disorders/Experiment 2
- Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients
- Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients/Experiment 1
- Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients/Experiment 1/Signature 1
- Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients/Experiment 1/Signature 2
- Metagenome-wide association of gut microbiome features for schizophrenia/Experiment 1
- Metagenome-wide association of gut microbiome features for schizophrenia/Experiment 2
- Metagenome-wide association of gut microbiome features for schizophrenia/Experiment 3
- Metagenome-wide association of gut microbiome features for schizophrenia/Experiment 4
- Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women
- Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 1
- Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 1/Signature 1
- Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women/Experiment 1/Signature 2
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 1
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 2
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 3
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 4
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 5
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 6
- Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 7
- Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 1
- Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 2
- Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza/Experiment 3
- Correlation of fecal metabolomics and gut microbiota in mice with endometriosis/Experiment 1
- Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients
- Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients/Experiment 9
- Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index/Experiment 1
- Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn's disease/Experiment 1
- Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn's disease/Experiment 2
- Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn's disease/Experiment 3
- Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn's disease/Experiment 4
- Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease/Experiment 5
- Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease/Experiment 6
- Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease/Experiment 7
- Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease/Experiment 2
- The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 1/Signature 1
- Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 1
- Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 2
- Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 4
- Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 5
- Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 4
- Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates/Experiment 6
- Shotgun sequencing of the vaginal microbiome reveals both a species and functional potential signature of preterm birth/Experiment 1
- Shotgun sequencing of the vaginal microbiome reveals both a species and functional potential signature of preterm birth/Experiment 2
- Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder/Experiment 1/Signature 1
- Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer/Experiment 1
- Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals/Experiment 1
- Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals/Experiment 2
- Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals/Experiment 3
- Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components/Experiment 1
- Acupoint Massage Therapy Alters the Composition of Gut Microbiome in Functional Constipation Patients/Experiment 2
- Differences in gut microbiota between allergic rhinitis, atopic dermatitis, and skin urticaria: A pilot study/Experiment 1
- Differences in gut microbiota between allergic rhinitis, atopic dermatitis, and skin urticaria: A pilot study/Experiment 2
- Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease/Experiment 1
- Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease/Experiment 2
- Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark/Experiment 1/Signature 1
- Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark/Experiment 1/Signature 2
- Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark/Experiment 2/Signature 1
- Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark/Experiment 4/Signature 1
- Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark/Experiment 6/Signature 2
- Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark/Experiment 7/Signature 1
- Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome/Experiment 1
- Biliary Microbiota in Choledocholithiasis and Correlation With Duodenal Microbiota/Experiment 1
- Effect of the HXBM408 bacteria on rat intestinal bacterial diversity and the metabolism of soybean isoflavones/Experiment 8
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 1
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 1/Signature 1
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 1/Signature 2
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 2
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 2/Signature 1
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 3
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 3/Signature 1
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 3/Signature 2
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 4
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 4/Signature 1
- Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals/Experiment 4/Signature 2
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 1
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 2
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 3
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 4
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 5
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 6
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 7
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 8
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 9
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 10
- Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy/Experiment 11
- The East Asian gut microbiome is distinct from colocalized White subjects and connected to metabolic health/Experiment 1
- Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease/Experiment 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 1/Signature 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 2
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 2/Signature 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 3
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 3/Signature 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4/Signature 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 4/Signature 2
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5/Signature 1
- Overabundance of Asaia and Serratia Bacteria Is Associated with Deltamethrin Insecticide Susceptibility in Anopheles coluzzii from Agboville, Côte d'Ivoire/Experiment 5/Signature 2
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 1
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 1/Signature 1
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 2
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 2/Signature 1
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 2/Signature 2
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 3
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 3/Signature 1
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 4
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 4/Signature 1
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 4/Signature 2
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 5
- Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation/Experiment 5/Signature 1
- Association of Bitter Taste Receptor T2R38 Polymorphisms, Oral Microbiota, and Rheumatoid Arthritis/Experiment 1
- Association of Bitter Taste Receptor T2R38 Polymorphisms, Oral Microbiota, and Rheumatoid Arthritis/Experiment 2
- Association of Bitter Taste Receptor T2R38 Polymorphisms, Oral Microbiota, and Rheumatoid Arthritis/Experiment 3
- Association of Bitter Taste Receptor T2R38 Polymorphisms, Oral Microbiota, and Rheumatoid Arthritis/Experiment 4
- Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer/Experiment 1
- Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer/Experiment 2
- Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer/Experiment 3
- Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer/Experiment 4
- Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease/Experiment 2
- Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease/Experiment 3
- Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease/Experiment 4
- Deep nasal sinus cavity microbiota dysbiosis in Parkinson's disease/Experiment 5
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 1
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 2
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 3
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 4
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 5
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 6
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 7
- Metagenomic Analysis Reveals the Heterogeneity of Conjunctival Microbiota Dysbiosis in Dry Eye Disease/Experiment 8
- Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome/Experiment 1
- Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome/Experiment 2
- Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome/Experiment 3
- Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome/Experiment 4
- Yoghurt consumption is associated with changes in the composition of the human gut microbiome and metabolome/Experiment 1/Signature 1
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 3/Signature 1
- Dysbiosis of skin microbiome and gut microbiome in melanoma progression/Experiment 4/Signature 1
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 1
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 1/Signature 1
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 1/Signature 2
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 2
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 2/Signature 1
- Assessing the Tsetse Fly Microbiome Composition and the Potential Association of Some Bacteria Taxa with Trypanosome Establishment/Experiment 2/Signature 2
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 1
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 1/Signature 1
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 1/Signature 2
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 3
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 3/Signature 1
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 3/Signature 2
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 4
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 4/Signature 1
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 5
- Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations/Experiment 5/Signature 1
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 1
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 1/Signature 1
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 1/Signature 2
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 2
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 2/Signature 1
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 2/Signature 2
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 3
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 3/Signature 1
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 3/Signature 2
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 4
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 4/Signature 1
- Topical Glaucoma Therapy Is Associated With Alterations of the Ocular Surface Microbiome/Experiment 4/Signature 2
- The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults/Experiment 2/Signature 1
- The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults/Experiment 4/Signature 2
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 3
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 4
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 5
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 6
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 7
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 8
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 9
- Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes/Experiment 10
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome/Experiment 1
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome/Experiment 1/Signature 1
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome/Experiment 1/Signature 2
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome/Experiment 2
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome/Experiment 2/Signature 1
- Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome/Experiment 2/Signature 2
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 1
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 2
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 3
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 4
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 5
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 6
- Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients/Experiment 7
- Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease/Experiment 3/Signature 2
- Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study/Experiment 1/Signature 2
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 1
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 1/Signature 1
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 1/Signature 2
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 2
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 2/Signature 1
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 2/Signature 2
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 3
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 3/Signature 1
- Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis/Experiment 3/Signature 2
- Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response/Experiment 12/Signature 1
- The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathy/Experiment 1/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 1/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 1/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 2/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 2/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 3
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 3/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 3/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 4
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 4/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 4/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 5
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 5/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 5/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 6
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 6/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 6/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 7
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 7/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 7/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 8
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 8/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 8/Signature 2
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 9
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 9/Signature 1
- Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data/Experiment 9/Signature 2
- Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection/Experiment 1
- Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection/Experiment 2
- Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection/Experiment 2
- Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection/Experiment 3
- Development of the oral resistome during the first decade of life
- The gut microbiome in social anxiety disorder: evidence of altered composition and function/Experiment 1
- Current levels of microplastic pollution impact wild seabird gut microbiomes/Experiment 4
- Current levels of microplastic pollution impact wild seabird gut microbiomes/Experiment 5
- Alterations of the intestinal microbiota in age-related macular degeneration
- Alterations of the intestinal microbiota in age-related macular degeneration/Experiment 1
- Alterations of the intestinal microbiota in age-related macular degeneration/Experiment 1/Signature 1
- Alterations of the intestinal microbiota in age-related macular degeneration/Experiment 1/Signature 2
- Alterations of the intestinal microbiota in age-related macular degeneration/Experiment 2
- Alterations of the intestinal microbiota in age-related macular degeneration/Experiment 2/Signature 1
- Alterations of the intestinal microbiota in age-related macular degeneration/Experiment 2/Signature 2
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 1
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 2
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 3
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 4
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 5
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 6
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 7
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 8
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 9
- Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients/Experiment 10
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 1/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 1/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 2/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 2/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 3
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 3/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 3/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 4
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 4/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 4/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 5
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 5/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 5/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 6
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 6/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 6/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 7
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 7/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 7/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 8
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 8/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 8/Signature 2
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 9
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 9/Signature 1
- Changes in the gut microbiota structure and function in rats with doxorubicin-induced heart failure/Experiment 9/Signature 2
- Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic
- Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 1
- Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 1/Signature 1
- Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic/Experiment 1/Signature 2
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 1
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 1/Signature 1
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 1/Signature 2
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 2
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 2/Signature 1
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 2/Signature 2
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 3
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 3/Signature 1
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 3/Signature 2
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4/Signature 1
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4/Signature 2
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 5
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 5/Signature 1
- Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 5/Signature 2
- Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet/Experiment 1/Signature 1
- Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 1
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 2
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 3
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 4
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 5
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 6
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 7
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 8
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 9
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 10
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 11
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 12
- Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma/Experiment 13
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 4/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 5/Signature 1
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 6/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 7/Signature 2
- The long-term gut bacterial signature of a wild primate is associated with a timing effect of pre- and postnatal maternal glucocorticoid levels/Experiment 8/Signature 2
- Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study/Experiment 1
- Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study/Experiment 2
- Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study/Experiment 3
- Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study/Experiment 4
- Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease/Experiment 4/Signature 2
- Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease/Experiment 5/Signature 2
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 2/Signature 1
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 2/Signature 2
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 7/Signature 1
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 7/Signature 2
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 11/Signature 1
- Long-term benefit of DAAs on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection/Experiment 14/Signature 2
- Alteration in gut mycobiota of patients with polycystic ovary syndrome/Experiment 2
- Alteration in gut mycobiota of patients with polycystic ovary syndrome/Experiment 2/Signature 1
- Alteration in gut mycobiota of patients with polycystic ovary syndrome/Experiment 2/Signature 2
- The Human Ocular Surface Microbiome and Its Associations with the Tear Proteome in Dry Eye Disease/Experiment 1
- The Human Ocular Surface Microbiome and Its Associations with the Tear Proteome in Dry Eye Disease/Experiment 2
- Smoking and salivary microbiota: a cross-sectional analysis of an Italian alpine population/Experiment 1
- Smoking and salivary microbiota: a cross-sectional analysis of an Italian alpine population/Experiment 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1/Signature 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 1/Signature 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 2/Signature 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 2/Signature 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 3
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 3/Signature 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 3/Signature 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 4
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 4/Signature 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 4/Signature 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 5
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 5/Signature 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 5/Signature 2
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 6
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 6/Signature 1
- Gut microbiota response to in vitro transit time variation is mediated by microbial growth rates, nutrient use efficiency and adaptation to in vivo transit time/Experiment 6/Signature 2
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 1
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 2
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 3
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 4
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 5
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 6
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 7
- Specific gastrointestinal microbiota profiles in Chinese Tan sheep are associated with lauric acid content in muscle/Experiment 8
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 1/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 2
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 2/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 3
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 3/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 4
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 4/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 5
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 5/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 6
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 6/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 7
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 7/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 7/Signature 2
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 8
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 8/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 9
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 9/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 10
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 10/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 11
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 11/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 12
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 12/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 13
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 13/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 14
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 14/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 15
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 15/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 16
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 16/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 17
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 17/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 18
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 18/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 19
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 19/Signature 1
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 20
- Surgery-induced gut microbial dysbiosis promotes cognitive impairment via regulation of intestinal function and the metabolite palmitic amide/Experiment 20/Signature 1
- Correlation of gut microbiota with leukopenia after chemotherapy in patients with colorectal cancer/Experiment 1/Signature 2
- Gut microbiomes of agropastoral children from the Adadle region of Ethiopia reflect their unique dietary habits/Experiment 1/Signature 2
- Gut microbiomes of agropastoral children from the Adadle region of Ethiopia reflect their unique dietary habits/Experiment 2/Signature 2
- Gut microbiomes of agropastoral children from the Adadle region of Ethiopia reflect their unique dietary habits/Experiment 7/Signature 2
- Gut microbiomes of agropastoral children from the Adadle region of Ethiopia reflect their unique dietary habits/Experiment 9/Signature 2
- Gut microbiota affects the estrus return of sows by regulating the metabolism of sex steroid hormones/Experiment 2/Signature 2
- Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites/Experiment 1/Signature 2
- Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India/Experiment 1
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 1/Signature 2
- Sex-specific differences in intestinal microbiota associated with cardiovascular diseases/Experiment 4/Signature 1
- Insights into estrogen impact in oral health & microbiome in COVID-19/Experiment 1
- Insights into estrogen impact in oral health & microbiome in COVID-19/Experiment 2
- Insights into estrogen impact in oral health & microbiome in COVID-19/Experiment 3
- Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 3
- Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 3/Signature 1
- Gut microbiota modulate CD8+ T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX/Experiment 3/Signature 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 1/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 1/Signature 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 2/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 3
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 3/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 3/Signature 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 4
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 4/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 4/Signature 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 5
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 5/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 5/Signature 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 6
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 6/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 6/Signature 2
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 7
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 7/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 8
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 8/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 9
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 9/Signature 1
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 10
- Short-term pectin-enriched smoothie consumption has beneficial effects on the gut microbiota of low-fiber consumers/Experiment 10/Signature 1
- Gastrointestinal Characteristics of Constipation from the Perspectives of Microbiome and Metabolome/Experiment 1/Signature 2
- Characteristics of the oral and gastric microbiome in patients with early-stage intramucosal esophageal squamous cell carcinoma/Experiment 1
- Characteristics of the oral and gastric microbiome in patients with early-stage intramucosal esophageal squamous cell carcinoma/Experiment 2
- Peripheral neuronal activation shapes the microbiome and alters gut physiology/Experiment 4
- Peripheral neuronal activation shapes the microbiome and alters gut physiology/Experiment 5
- Peripheral neuronal activation shapes the microbiome and alters gut physiology/Experiment 6
- Peripheral neuronal activation shapes the microbiome and alters gut physiology/Experiment 7
- Peripheral neuronal activation shapes the microbiome and alters gut physiology/Experiment 8
- The oral cavity and intestinal microbiome in children with functional constipation
- The oral cavity and intestinal microbiome in children with functional constipation/Experiment 1
- The oral cavity and intestinal microbiome in children with functional constipation/Experiment 1/Signature 1
- The oral cavity and intestinal microbiome in children with functional constipation/Experiment 1/Signature 2
- Diet changes due to urbanization in South Africa are linked to microbiome and metabolome signatures of Westernization and colorectal cancer/Experiment 1/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 1/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 1/Signature 2
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 2
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 2/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 3
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 3/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 3/Signature 2
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 4
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 4/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 5/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 6
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 6/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 7/Signature 1
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 8
- Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome/Experiment 8/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 1/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 1/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 2/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 2/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 3
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 3/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 4
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 4/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 4/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 5
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 5/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 5/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 6
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 6/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 6/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 7
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 7/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 7/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 8
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 8/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 8/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 9
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 9/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 10
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 10/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 10/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 11
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 11/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 12
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 12/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 12/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 13
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 13/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 13/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 14
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 14/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 14/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 15
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 15/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 15/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 16
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 16/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 16/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 17
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 17/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 17/Signature 2
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 18
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 18/Signature 1
- Oral microbiome dysbiosis among cigarette smokers and smokeless tobacco users compared to non-users/Experiment 18/Signature 2
- 16S rRNA gene sequencing reveals altered gut microbiota in young adults with schizophrenia and prominent negative symptoms/Experiment 1/Signature 2
- Faecal microbiota of schoolchildren is associated with nutritional status and markers of inflammation: a double-blinded cluster-randomized controlled trial using multi-micronutrient fortified rice/Experiment 5/Signature 2
- Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 1
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 1/Signature 1
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 1/Signature 2
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 2
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 2/Signature 1
- Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome/Experiment 2/Signature 2
- Integrating respiratory microbiome and host immune response through machine learning for respiratory tract infection diagnosis/Experiment 1
- Gut microbiome and serum metabolome alterations associated with lactose intolerance (LI): a case‒control study and paired-sample study based on the American Gut Project (AGP)/Experiment 1/Signature 2
- Mild atopic dermatitis is characterized by increase in non-staphylococcus pathobionts and loss of specific species/Experiment 1
- Mild atopic dermatitis is characterized by increase in non-staphylococcus pathobionts and loss of specific species/Experiment 2
- Mild atopic dermatitis is characterized by increase in non-staphylococcus pathobionts and loss of specific species/Experiment 3
- Nepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized/Experiment 1
- Nepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized/Experiment 2
- Nepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized/Experiment 3
- Nepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized/Experiment 4
- Nepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized/Experiment 5
- The Parkinson's disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration/Experiment 8/Signature 1
- Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan/Experiment 1
- Increase in body weight is lowered when mice received fecal microbiota transfer from donor mice treated with the AT1 receptor antagonist telmisartan/Experiment 2
- Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin/Experiment 2/Signature 1
- Gut dysbiosis narrative in psoriasis: matched-pair approach identifies only subtle shifts correlated with elevated fecal calprotectin/Experiment 2/Signature 2
- New insights into the combined effects of aflatoxin B1 and Eimeria ovinoidalis on uterine function by disrupting the gut-blood-reproductive axis in sheep/Experiment 5
- New insights into the combined effects of aflatoxin B1 and Eimeria ovinoidalis on uterine function by disrupting the gut-blood-reproductive axis in sheep/Experiment 6
- New insights into the combined effects of aflatoxin B1 and Eimeria ovinoidalis on uterine function by disrupting the gut-blood-reproductive axis in sheep/Experiment 7
- New insights into the combined effects of aflatoxin B1 and Eimeria ovinoidalis on uterine function by disrupting the gut-blood-reproductive axis in sheep/Experiment 8
- New insights into the combined effects of aflatoxin B1 and Eimeria ovinoidalis on uterine function by disrupting the gut-blood-reproductive axis in sheep/Experiment 9
- A Lactobacillus consortium provides insights into the sleep-exercise-microbiome nexus in proof of concept studies of elite athletes and in the general population/Experiment 4
- Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model/Experiment 1/Signature 1
- Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model/Experiment 3/Signature 1
- Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model/Experiment 4/Signature 1
- Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model/Experiment 4/Signature 2
- Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short-Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model/Experiment 5/Signature 1
- Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 1/Signature 1
- Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 2/Signature 1
- Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 2/Signature 2
- Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 3/Signature 1
- Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 3/Signature 2
- Dietary selective effects manifest in the human gut microbiota from species composition to strain genetic makeup/Experiment 4/Signature 2
- The difference of oropharyngeal microbiome during acute respiratory viral infections in infants and children/Experiment 3
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 1/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 1/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 2/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 2/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 3
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 3/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 3/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 4
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 4/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 5
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 5/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 5/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 6
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 6/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 6/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 7
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 7/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 7/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 8
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 8/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 8/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 9
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 9/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 9/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 10
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 10/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 10/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 11
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 11/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 11/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 12
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 12/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 12/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 13
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 13/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 13/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 14
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 14/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 14/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 15
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 15/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 16
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 16/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 17
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 17/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 17/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 18
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 18/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 19
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 19/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 19/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 20
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 20/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 22/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 23
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 23/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 23/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 24
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 24/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 24/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 25
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 25/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 25/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 26
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 26/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 26/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 27
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 27/Signature 1
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 27/Signature 2
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 28
- Gut microbiota modulation via fecal microbiota transplantation mitigates hyperoxaluria and calcium oxalate crystal depositions induced by high oxalate diet/Experiment 28/Signature 1
- Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota/Experiment 1
- Personalized prediction of glycemic responses to food in women with diet-treated gestational diabetes: the role of the gut microbiota/Experiment 2/Signature 1
- Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure/Experiment 3/Signature 1
- Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure/Experiment 4/Signature 2
- Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure/Experiment 5/Signature 1
- Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure/Experiment 6/Signature 1
- Fecal bacterial biomarkers and blood biochemical indicators as potential key factors in the development of colorectal cancer/Experiment 6
- Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 1
- Smoking-related gut microbiota alteration is associated with obesity and obesity-related diseases: results from two cohorts with sibling comparison analyses/Experiment 7
- Maternal balanced energy-protein supplementation reshapes the maternal gut microbiome and enhances carbohydrate metabolism in infants: a randomized controlled trial/Experiment 2/Signature 1
- Bifidobacteria support optimal infant vaccine responses
- Bifidobacteria support optimal infant vaccine responses/Experiment 1
- Bifidobacteria support optimal infant vaccine responses/Experiment 1/Signature 1
- Bifidobacteria support optimal infant vaccine responses/Experiment 1/Signature 2
- Bifidobacteria support optimal infant vaccine responses/Experiment 2
- Bifidobacteria support optimal infant vaccine responses/Experiment 2/Signature 1
- Bifidobacteria support optimal infant vaccine responses/Experiment 2/Signature 2
- Bifidobacteria support optimal infant vaccine responses/Experiment 3
- Bifidobacteria support optimal infant vaccine responses/Experiment 3/Signature 1
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1/Signature 1
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 1
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1/Signature 2
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 2/Signature 1
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3
- Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 3/Signature 1
- Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters
- Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
- Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1/Signature 1
- Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1/Signature 2
- Study 83
- Study 83/Experiment 1
- Nasopharyngeal Microbiome Community Composition and Structure Is Associated with Severity of COVID-19 Disease and Breathing Treatment/Experiment 2
- Body site-typical microbiome signatures for adults
- Body site-typical microbiome signatures for adults/Experiment 1
- Body site-typical microbiome signatures for adults/Experiment 2
- Body site-typical microbiome signatures for adults/Experiment 3
- Body site-typical microbiome signatures for adults/Experiment 4
- Body site-typical microbiome signatures for adults/Experiment 5
- Body site-typical microbiome signatures for adults/Experiment 6
- Body site-typical microbiome signatures for adults/Experiment 7
- Body site-typical microbiome signatures for adults/Experiment 8
- Body site-typical microbiome signatures for adults/Experiment 9
- Body site-typical microbiome signatures for adults/Experiment 10
- Body site-typical microbiome signatures for adults/Experiment 10/Signature 1
- Body site-typical microbiome signatures for adults/Experiment 11
- Body site-typical microbiome signatures for children
- Body site-typical microbiome signatures for children/Experiment 1
- Investigation of systemic granulomatosis in cultured meagre, Argyrosomus regius, using clinical metagenomics/Experiment 1
- Investigation of systemic granulomatosis in cultured meagre, Argyrosomus regius, using clinical metagenomics/Experiment 2
- Investigation of systemic granulomatosis in cultured meagre, Argyrosomus regius, using clinical metagenomics/Experiment 3
- Stachyose ameliorates obesity-related metabolic syndrome via improving intestinal barrier function and remodeling gut microbiota/Experiment 1
- Characterization of the Gut and Skin Microbiome over Time in Young Children with IgE-Mediated Food Allergy
